IRE: Gefitinib
IRE is a Ligand Of Interest in 4I22 designated by the RCSB
| Best-fitted instance in this entry |
| Other instances in this entry |
| Best-fitted instance in this entry |
| Best-fitted PDB instances with same target (top 5) |
| Best-fitted instance in this entry |
| Best-fitted PDB instances with different target (top 5) |
| Identifier | Ranking for goodness of fit | Ranking for geometry | Real space R factor | Real space correlation coefficient | RMSZ-bond-length | RMSZ-bond-angle | Outliers of bond length | Outliers of bond angle | Atomic clashes | Stereochemical errors | Model completeness | Average occupancy |
| 4I22_IRE_A_9001 | 87% | 28% | 0.084 | 0.962 | 1.88 | 0.96 | 12 | 1 | 1 | 0 | 100% | 1 |
| 2ITO_IRE_A_2020 | 68% | 16% | 0.117 | 0.93 | 1.45 | 2.11 | 5 | 12 | 3 | 0 | 100% | 1 |
| 2ITZ_IRE_A_2021 | 52% | 12% | 0.138 | 0.894 | 1.45 | 2.47 | 5 | 16 | 5 | 0 | 100% | 1 |
| 4WKQ_IRE_A_1101 | 48% | 11% | 0.15 | 0.894 | 1.57 | 2.5 | 4 | 14 | 1 | 0 | 100% | 1 |
| 3UG2_IRE_A_1 | 39% | 12% | 0.203 | 0.914 | 1.41 | 2.55 | 4 | 15 | 2 | 0 | 100% | 0.5 |
| 2ITY_IRE_A_2020 | 38% | 14% | 0.174 | 0.878 | 1.78 | 1.99 | 5 | 13 | 10 | 0 | 100% | 1 |
| 9D5E_IRE_A_701 | 89% | 12% | 0.08 | 0.967 | 1.63 | 2.33 | 5 | 12 | 1 | 0 | 100% | 1 |
| 9D5H_IRE_A_701 | 78% | 11% | 0.1 | 0.948 | 2.26 | 1.89 | 12 | 10 | 1 | 0 | 100% | 1 |
| 5Y7Z_IRE_A_401 | 51% | 10% | 0.127 | 0.879 | 1.8 | 2.33 | 9 | 18 | 1 | 0 | 100% | 1 |